People · Operator

Abhinav Nicholas Shukla

Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology

1
Companies
1
Filings
$62.6M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Artio Medical, Inc.BiotechnologySeries B$62.6M$70.7M2021
Operator network

Abhinav Nicholas Shukla at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Sean Morris · 7 companies · 1 sharedSean MorrisJames M. Schultz · 3 companies · 1 sharedJames M. SchultzNathaniel Hagedorn · 3 companies · 1 sharedNathaniel HagedornFrank Nicholas Franano · 2 companies · 1 sharedFrank Nicholas Fr…Jeff M. Weinrich · 2 companies · 1 sharedJeff M. WeinrichJenny Nicholas Martin · 2 companies · 1 sharedJenny Nicholas Ma…Abhinav M. Shukla · 1 companies · 1 sharedAbhinav M. ShuklaJohn M. Ayres · 1 companies · 1 sharedJohn M. AyresJoseph M. McConnell · 1 companies · 1 sharedJoseph M. McConne…Maria M. Sainz · 1 companies · 1 sharedMaria M. SainzMaria Nicholas Sainz · 1 companies · 1 sharedMaria Nicholas Sa…Nathaniel Nicholas Hagedorn · 1 companies · 1 sharedNathaniel Nichola…Artio Medical, Inc. · $62.6M raisedArtio Medical, Inc.Abhinav Nicholas ShuklaAS
Abhinav Nicholas Shukla Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Abhinav Nicholas Shukla on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Sean Morris17
James M. Schultz13
Nathaniel Hagedorn13
Frank Nicholas Franano12
Jenny Nicholas Martin12
Jeff M. Weinrich12
Maria M. Sainz11
Joseph M. McConnell11
Nathaniel Nicholas Hagedorn11
Abhinav M. Shukla11
John M. Ayres11
Maria Nicholas Sainz11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.